Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed BSE that its trading window for dealing in company shares will be closed from April 1, 2026, for all designated persons. The closure is a routine compliance step taken ahead of declaring the audited financial results for the six months and full financial year ending March 31, 2026. The trading window will reopen 48 hours after the financial results are officially announced to the stock exchange. The intimation was signed by Managing Director Bharat Sharma on March 26, 2026.
This is a standard regulatory filing with no direct impact on shareholders. The window closure simply prevents company insiders from trading shares while they may have access to unpublished financial results, and signals that audited FY26 results will be announced soon after the window reopens.